Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2025 Earnings Call Transcript February 25, 2026
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $0.02.
Greg Martini: Forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the...
